The CD4+ TCs and CD8+ TCs from gout remission were enriched in chemokines, such as CXCR4, as well as various antiinflammatory regulators (TNFAIP3, ZFP36, and SMAD7; an antagonist of TGF-β signaling). Here, CXCR4 is linked to gout.